Literature DB >> 11602743

Infection and activation of monocytes by Marburg and Ebola viruses.

U Ströher1, E West, H Bugany, H D Klenk, H J Schnittler, H Feldmann.   

Abstract

In this study we investigated the effects of Marburg virus and Ebola virus (species Zaire and Reston) infections on freshly isolated suspended monocytes in comparison to adherent macrophages under culture conditions. Our data showed that monocytes are permissive for both filoviruses. As is the case in macrophages, infection resulted in the activation of monocytes which was largely independent of virus replication. The activation was triggered similarly by Marburg and Ebola viruses, species Zaire and Reston, as indicated by the release of the proinflammatory cytokines interleukin-1beta (IL-1beta), tumor necrosis factor alpha, and IL-6 as well as the chemokines IL-8 and gro-alpha. Our data suggest that infected monocytes may play an important role in the spread of filoviruses and in the pathogenesis of filoviral hemorrhagic disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602743      PMCID: PMC114683          DOI: 10.1128/JVI.75.22.11025-11033.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  C-C and C-X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions.

Authors:  F W Luscinskas; R E Gerszten; E A Garcia-Zepeda; Y C Lim; M Yoshida; H A Ding; M A Gimbrone; A D Luster; A Rosenzweig
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

2.  Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells.

Authors:  M G Netea; C H Selzman; B J Kullberg; J M Galama; A Weinberg; A F Stalenhoef; J W Van der Meer; C A Dinarello
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

3.  Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.

Authors:  M Gupta; S Mahanty; R Ahmed; P E Rollin
Journal:  Virology       Date:  2001-05-25       Impact factor: 3.616

4.  Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Authors:  Z Y Yang; H J Duckers; N J Sullivan; A Sanchez; E G Nabel; G J Nabel
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

5.  Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.

Authors:  Stephen Y Chan; Melissa C Ma; Mark A Goldsmith
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

6.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

Authors:  S P Fisher-Hoch; G S Platt; G H Neild; T Southee; A Baskerville; R T Raymond; G Lloyd; D I Simpson
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

8.  Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells.

Authors:  G Haraldsen; D Kvale; B Lien; I N Farstad; P Brandtzaeg
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

9.  Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management.

Authors:  S P Fisher-Hoch; G S Platt; G Lloyd; D I Simpson; G H Neild; A J Barrett
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

10.  A Trojan Horse mechanism for the spread of visna virus in monocytes.

Authors:  R Peluso; A Haase; L Stowring; M Edwards; P Ventura
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

View more
  88 in total

1.  Identification of a small-molecule entry inhibitor for filoviruses.

Authors:  Arnab Basu; Bing Li; Debra M Mills; Rekha G Panchal; Steven C Cardinale; Michelle M Butler; Norton P Peet; Helena Majgier-Baranowska; John D Williams; Ishan Patel; Donald T Moir; Sina Bavari; Ranjit Ray; Michael R Farzan; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

Authors:  Graham Simmons; Andrew J Rennekamp; Ning Chai; Luk H Vandenberghe; James L Riley; Paul Bates
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

4.  Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.

Authors:  Hideki Ebihara; Barry Rockx; Andrea Marzi; Friederike Feldmann; Elaine Haddock; Douglas Brining; Rachel A LaCasse; Don Gardner; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry.

Authors:  Derek Dube; Kathryn L Schornberg; Charles J Shoemaker; Sue E Delos; Tzanko S Stantchev; Kathleen A Clouse; Christopher C Broder; Judith M White
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-03       Impact factor: 11.205

6.  Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function.

Authors:  Victoria M Wahl-Jensen; Tatiana A Afanasieva; Jochen Seebach; Ute Ströher; Heinz Feldmann; Hans-Joachim Schnittler
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.

Authors:  Akihito Yonezawa; Marielle Cavrois; Warner C Greene
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells.

Authors:  Joshua C Johnson; Osvaldo Martinez; Anna N Honko; Lisa E Hensley; Gene G Olinger; Christopher F Basler
Journal:  Antiviral Res       Date:  2014-05-09       Impact factor: 5.970

Review 9.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

10.  Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

Authors:  Andrea Rivera; Ilhem Messaoudi
Journal:  ACS Infect Dis       Date:  2015-03-30       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.